Prokocimer Philippe

Chief Medical Officer at Trius Therapeutics Inc · on record since Aug 2, 2010

Insider trading activity of Prokocimer Philippe

Transactions on record: 28; since Nov 5, 2010

Open-market buys: 0

Open-market sells: 7; $335.7K

Companies traded: 1; last filing Sep 13, 2013

Figures computed from official regulatory filings — .

Companies where Prokocimer Philippe has traded

Trius Therapeutics Inc28 tx · $3M · Sep 13, 2013

Track record of Prokocimer Philippe

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Prokocimer Philippe

Co-insiders of Prokocimer Philippe

ATWOOD BRIAN GTrius Therapeutics Inc
Bartizal KenTrius Therapeutics Inc
Buatois EricTrius Therapeutics Inc
CASH HARVEY BTrius Therapeutics Inc
CLEVELAND BRUCE ATrius Therapeutics Inc
EASTHAM KARINTrius Therapeutics Inc
Ehrlich Christopher BTrius Therapeutics Inc
Finn JohnTrius Therapeutics Inc
Fischer Seth H.Z.Trius Therapeutics Inc
GIANOS PHILIP TTrius Therapeutics Inc
Grais Linda STrius Therapeutics Inc
HEALY JAMESTrius Therapeutics Inc
Holmes W StephenTrius Therapeutics Inc
InterWest Management Partners IX, LLCTrius Therapeutics Inc
InterWest Partners IX, LPTrius Therapeutics Inc
KABAKOFF DAVID STrius Therapeutics Inc
Kjellson Nina STrius Therapeutics Inc
Kliman Gilbert HTrius Therapeutics Inc
KPCB PANDEMIC & BIO DEFENSE FUND LLCTrius Therapeutics Inc
KPCB PBD Associates, LLCTrius Therapeutics Inc
KPCB PBD Founders Fund, LLCTrius Therapeutics Inc
MORNEAU MICHAELTrius Therapeutics Inc
NASR KHALEDTrius Therapeutics Inc
O'Leary BrendanTrius Therapeutics Inc
Onaitis MatthewTrius Therapeutics Inc
ORONSKY ARNOLD LTrius Therapeutics Inc
Pepper Douglas ATrius Therapeutics Inc
POWELL MICHAELTrius Therapeutics Inc
Prism Venture Partners V-A LPTrius Therapeutics Inc
Prism Venture Partners V L PTrius Therapeutics Inc
Rosch Thomas LTrius Therapeutics Inc
Schmid John P.Trius Therapeutics Inc

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Trius Therapeutics IncListing unverified	Sep 13, 2013	OtherD (derivative)	-150,000	7.37 USD	$1.1M	SEC
Trius Therapeutics IncListing unverified	Sep 13, 2013	OtherD (derivative)	-16,569	12.21 USD	$202.3K	SEC
Trius Therapeutics IncListing unverified	Sep 13, 2013	OtherD (derivative)	-1,744	12.21 USD	$21.3K	SEC
Trius Therapeutics IncListing unverified	Sep 13, 2013	Other	-12,190	—	n/a (No price was disclosed in the filing)	SEC
Trius Therapeutics IncListing unverified	Sep 13, 2013	Other	-82,022	—	n/a (No price was disclosed in the filing)	SEC
Trius Therapeutics IncListing unverified	Sep 13, 2013	OtherD (derivative)	-50,000	10.00 USD	$500K	SEC
Trius Therapeutics IncListing unverified	Sep 13, 2013	OtherD (derivative)	-90,000	8.70 USD	$783K	SEC
Trius Therapeutics IncListing unverified	Jul 1, 2013	Sell	-2,000	8.14 USD	$16.3K	SEC
Trius Therapeutics IncListing unverified	Jun 3, 2013	Sell	-2,000	7.75 USD	$15.5K	SEC
Trius Therapeutics IncListing unverified	May 28, 2013	Sell	-12,000	7.65 USD	$91.8K	SEC
Trius Therapeutics IncListing unverified	May 28, 2013	Sell	-12,000	7.93 USD	$95.2K	SEC
Trius Therapeutics IncListing unverified	May 15, 2013	Sell	-12,000	7.65 USD	$91.8K	SEC
Trius Therapeutics IncListing unverified	Mar 11, 2013	AwardD (derivative)	150,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Trius Therapeutics IncListing unverified	Mar 27, 2012	Exercise	6,244	0.52 USD	$3.2K	SEC
Trius Therapeutics IncListing unverified	Mar 27, 2012	ExerciseD (derivative)	-4,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Trius Therapeutics IncListing unverified	Mar 27, 2012	Exercise	4,000	0.52 USD	$2.1K	SEC
Trius Therapeutics IncListing unverified	Mar 27, 2012	ExerciseD (derivative)	-6,244	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Trius Therapeutics IncListing unverified	Mar 12, 2012	AwardD (derivative)	90,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Trius Therapeutics IncListing unverified	Jan 18, 2012	ExerciseD (derivative)	-4,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Trius Therapeutics IncListing unverified	Jan 18, 2012	Exercise	4,000	0.52 USD	$2.1K	SEC
Trius Therapeutics IncListing unverified	Nov 2, 2011	Sell	-1,687	7.45 USD	$12.6K	SEC
Trius Therapeutics IncListing unverified	Nov 2, 2011	Sell	-1,687	7.45 USD	$12.6K	SEC
Trius Therapeutics IncListing unverified	Oct 6, 2011	Exercise	4,000	0.52 USD	$2.1K	SEC
Trius Therapeutics IncListing unverified	Oct 6, 2011	ExerciseD (derivative)	-4,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Trius Therapeutics IncListing unverified	Aug 24, 2011	Exercise	4,070	0.52 USD	$2.1K	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Trius Therapeutics IncListing unverified	Sep 13, 2013	OtherD (derivative)	-150,000	7.37 USD	$1.1M	SEC
Trius Therapeutics IncListing unverified	Sep 13, 2013	OtherD (derivative)	-16,569	12.21 USD	$202.3K	SEC
Trius Therapeutics IncListing unverified	Sep 13, 2013	OtherD (derivative)	-1,744	12.21 USD	$21.3K	SEC
Trius Therapeutics IncListing unverified	Sep 13, 2013	Other	-12,190	—	n/a (No price was disclosed in the filing)	SEC
Trius Therapeutics IncListing unverified	Sep 13, 2013	Other	-82,022	—	n/a (No price was disclosed in the filing)	SEC
Trius Therapeutics IncListing unverified	Sep 13, 2013	OtherD (derivative)	-50,000	10.00 USD	$500K	SEC
Trius Therapeutics IncListing unverified	Sep 13, 2013	OtherD (derivative)	-90,000	8.70 USD	$783K	SEC
Trius Therapeutics IncListing unverified	Jul 1, 2013	Sell	-2,000	8.14 USD	$16.3K	SEC
Trius Therapeutics IncListing unverified	Jun 3, 2013	Sell	-2,000	7.75 USD	$15.5K	SEC
Trius Therapeutics IncListing unverified	May 28, 2013	Sell	-12,000	7.65 USD	$91.8K	SEC
Trius Therapeutics IncListing unverified	May 28, 2013	Sell	-12,000	7.93 USD	$95.2K	SEC
Trius Therapeutics IncListing unverified	May 15, 2013	Sell	-12,000	7.65 USD	$91.8K	SEC
Trius Therapeutics IncListing unverified	Mar 11, 2013	AwardD (derivative)	150,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Trius Therapeutics IncListing unverified	Mar 27, 2012	Exercise	6,244	0.52 USD	$3.2K	SEC
Trius Therapeutics IncListing unverified	Mar 27, 2012	ExerciseD (derivative)	-4,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Trius Therapeutics IncListing unverified	Mar 27, 2012	Exercise	4,000	0.52 USD	$2.1K	SEC
Trius Therapeutics IncListing unverified	Mar 27, 2012	ExerciseD (derivative)	-6,244	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Trius Therapeutics IncListing unverified	Mar 12, 2012	AwardD (derivative)	90,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Trius Therapeutics IncListing unverified	Jan 18, 2012	ExerciseD (derivative)	-4,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Trius Therapeutics IncListing unverified	Jan 18, 2012	Exercise	4,000	0.52 USD	$2.1K	SEC
Trius Therapeutics IncListing unverified	Nov 2, 2011	Sell	-1,687	7.45 USD	$12.6K	SEC
Trius Therapeutics IncListing unverified	Nov 2, 2011	Sell	-1,687	7.45 USD	$12.6K	SEC
Trius Therapeutics IncListing unverified	Oct 6, 2011	Exercise	4,000	0.52 USD	$2.1K	SEC
Trius Therapeutics IncListing unverified	Oct 6, 2011	ExerciseD (derivative)	-4,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Trius Therapeutics IncListing unverified	Aug 24, 2011	Exercise	4,070	0.52 USD	$2.1K	SEC